
Peptide Therapeutics Targeting Alzheimer’s Disease: An Overview of Aβ Aggregation Inhibitors
Alzheimer’s disease (AD) remains one of the most challenging neurodegenerative disorders worldwide, characterized by progressive cognitive decline and memory impairment. Despite decades of research, therapeutic